
DoP clears Suven Pharma, Cohance Lifesciences merger
Mumbai: Advent International backed CDMO Suven Pharmaceuticals has received final approval from the Department of Pharmaceuticals (DoP), to implement the proposed merger with Cohance Lifescience. In a stock exchange filing the CDMO informed that "the …